The invention provides that heterocyclic Schiff bases posses protein
antiglycation potential in hyperglycemia. The novel antiglycation agents
3-6 showed a moderate to potent antiglycation activity.
Journal
Title
United States, Patent Application Publication, Pub. No.: US 2014/0221429 Al